- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00875862
Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks
Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks: A Randomized, Triple-Masked, Placebo-Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Specific Aim: To determine if, compared with usual and customary analgesia, the addition of an ambulatory continuous interscalene nerve block will result in increased shoulder abduction following treatment for adhesive capsulitis of the shoulder.
Hypothesis: Following shoulder manipulation under a single-injection interscalene block for adhesive capsulitis, adding a three-day ambulatory continuous interscalene nerve blcok to usual and customary post-manipulation analgesia will result in a significantly greater shoulder abduction improvement the day following the manipulation.
Secondary Specific Aims: To determine if, compared with usual and customary analgesia, the addition of an ambulatory continuous interscalene nerve block will result in an increased quality-of-life and shoulder range-of-motion, as well as a decreased chronic pain following treatment for adhesive capsulitis of the shoulder.
Hypothesis 1: Following shoulder manipulation under a single-injection interscalene blcok for adhesive capsulitis, adding a three-day ambulatory continuous interscalene nerve block to usual and customary post-manipulation analgesia will result in a significantly increased quality-of-life improvement and shoulder range-of-motion compared wiht baseline values after three months.
Hypothesis 2: Following shoulder manipulation undera a single-injection interscalene block for adhesive capsulitis, adding a three-day ambulatory continuous interscalene nerve block to usual and costomary post-manipulation analgesia will result in a significantly decreased chronic pain compared with basedline falues after three months.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92103
- UCSD Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Undergoing theraputic manipulation for adhesive capsulitis of the shoulder
- age 18 years or older
- accepting a single-injection nerve block for manipulation
- understanding possible perineural infusion-related complications, study protocol, and catheter/pump care
- having caretaker through the first night after manipulation
- having an ASA physical status classification of 1-3
Exclusion Criteria:
- Any contraindications for a CISB
- any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery
- known allergy or other contraindication to the study medications
- pregnancy
- known hepatic or renal insufficiency/disease
- peripheral neuropathy of the surgical extremity
- morbid obesity
- inability to communicate with the investigators and hospital staff
- moderate-to-severe shoulder arthritis
- immunocompromised status of any etiology
- incarceration
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: 1. 0.2% Ropivicaine perinueral infusion
Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy).
They will then be randomized to 0.2% Ropivicaine attached to the perineural catheter and an infusion will be initiated.
The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.
|
Patients will be randomized to one of two groups: 0.2% Ropiviciane or normal saline in the infusion pump, following a shoulder manipulation for adhesive capsulitis.
The patients will be followed by doctors and study staff to assess pain, range-of-motion and quality-of-life.
|
PLACEBO_COMPARATOR: 2. Normal Saline perineural infusion
Patients will receive normal standard of care post-manipulation (single-injection brachial plexus nerve block, oral analgesics, and cold therapy).
They will then be randomized to normal saline attached to the perineural catheter and an infusion will be initiated.
The outcome measures will be assessed by study staff on the phone and at regular visits to the surgeon's office.
|
Patients will be randomized to one of two groups: 0.2% Ropiviciane or normal saline in the infusion pump, following a shoulder manipulation for adhesive capsulitis.
The patients will be followed by doctors and study staff to assess pain, range-of-motion and quality-of-life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Passive glenohumeral abduction, as evaluated using standard goniometry restricting scapular movement in a supine position. The difference in abduction the day following manipulation compared with the pre-manipulation value, expressed as a percentage.
Time Frame: change from baseline: measured immediately prior to manipulation and the morning following the manipulation.
|
change from baseline: measured immediately prior to manipulation and the morning following the manipulation.
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Adhesive Capsulitis
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesive Capsulitis
-
Daniel G. RendeiroCompletedAdhesive Capsulitis of Shoulder | Frozen Shoulder | Shoulder Adhesive CapsulitisUnited States
-
University of MalayaNot yet recruitingAdhesive Capsulitis of Shoulder
-
Taipei Veterans General Hospital, TaiwanRecruitingAdhesive Capsulitis of ShoulderTaiwan
-
Taif UniversityRecruitingAdhesive Capsulitis of ShoulderSaudi Arabia
-
Cairo UniversityNot yet recruitingAdhesive Capsulitis of Shoulder
-
Health Education Research Foundation (HERF)RecruitingAdhesive Capsulitis of ShoulderPakistan
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
-
Balikesir UniversityCompletedAdhesive Capsulitis of Shoulder
-
Cairo UniversityRecruitingAdhesive Capsulitis of ShoulderEgypt
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
Clinical Trials on Interscalene catheter with Ropivicaine or normal saline
-
Stanford UniversityCompletedAnesthesia, Local | Upper Extremity Injury | Phrenic Nerve Paralysis | Phrenic Nerve Palsy on the Left | Phrenic Nerve Palsy on the RightUnited States
-
University of California, San FranciscoCompletedPost-operative Surgical PainUnited States
-
University of California, San DiegoCompletedBreast Cancer | Mastectomy | Paravertebral Catheter InsertionUnited States
-
Seoul National University HospitalCompletedRetrograde Bladder FillKorea, Republic of
-
OAD OrthopaedicsUnknownFrozen ShoulderUnited States
-
University of PittsburghCompletedEnhanced Recovery After Surgery | Laparoscopic HysterectomyUnited States
-
Uppsala County Council, SwedenRecruitingNecrotizing Enterocolitis | Time to Full Enteral NutritionSweden
-
Tri-Service General HospitalCompleted
-
Coney Island Hospital, Brooklyn, NYCompletedEnd Stage Renal Disease | Hemodialysis Access Failure | Hemodialysis Complication | Acute Renal Failure | Hemodialysis Catheter Infection | Hemodialysis Catheter-Associated Bacteremia
-
University Health Network, TorontoCompleted